Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
about
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis VaccinesThe influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanismsComplement evasion by Bordetella pertussis: implications for improving current vaccinesCrescentic acute glomerulonephritis with isolated C3 deposition: a case report and review of literature.In-silico prediction and deep-DNA sequencing validation indicate phase variation in 115 Neisseria meningitidis genes.The biology of Neisseria adhesins.Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.Innate immunity and neuroinflammation.Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.Endolymphatic sac involvement in bacterial meningitis.A humanized model of microvascular infection.
P2860
Q26782340-ADAAE0D9-8DEB-4ED7-BF52-536467E3EFE1Q33535924-E7B9CF51-BBB5-43F3-8B1E-3483F52A6C41Q33613839-814D379F-8F0C-4676-9092-AE9403E771B4Q33642649-1EE4B379-2848-41F2-A3DC-04AC28E06C88Q35015208-E7A52EB8-BED8-4230-8E6B-382CE35D5593Q35197120-C10BA91F-25A3-4E2C-AB66-F63D07169986Q35406436-DF7B42D2-3FB4-42C1-97DD-785E839D4F7DQ36177419-22510956-3E02-4DDD-9C05-35B0D1BF27C8Q37651436-E93EB594-A3A2-4AA7-9D02-CE3269B1797AQ37701996-3E8D81FC-CD83-4AFB-8838-7A9D876E75A8Q37857246-68E4BD12-9E75-4E9A-9603-435A19BD0D2CQ38120744-2D272AE3-70B9-45B7-869E-7F93F4E03B42Q38235833-7743D5A3-4BB8-4F25-93BD-A26526E629DFQ40943128-1F685587-5E33-4009-9672-6DC5C47AE756Q41867568-90DF48DA-5C31-4023-AA3D-471768ECFCD5Q41960707-2B186749-D0D6-4F82-A799-B88DC1D6FDC0Q42231822-2A40B29F-977A-4C1D-8BE9-323126593461Q51443706-CE0DC153-A16F-4AB0-ADD8-CA6B73095C1A
P2860
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@en
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@nl
type
label
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@en
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@nl
prefLabel
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@en
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
@nl
P2860
P921
P1433
P1476
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing
@en
P2093
Bridget Gollan
Christoph M Tang
P2860
P356
10.1016/J.VACCINE.2008.11.059
P407
P478
26 Suppl 8
P577
2008-12-01T00:00:00Z